GSK’s DREAMM-7 trial shows promising results for Blenrep in multiple myeloma

Pallavi Madhiraju- November 28, 2023 0

GSK plc has unveiled positive outcomes from the DREAMM-7 head-to-head phase III trial, evaluating Blenrep (belantamab mafodotin) as a treatment for relapsed or refractory multiple ... Read More

Legend Biotech announces submission of CARVYKTI application to EMA for multiple myeloma

Pallavi Madhiraju- May 28, 2023 0

Legend Biotech has announced the submission of a Type II variation application to the European Medicines Agency (EMA) for CARVYKTI (ciltacabtagene autoleucel or cilta-cel), based ... Read More

Natco Pharma launches PrNAT-LENALIDOMIDE Capsules in Canada

pallavi123- September 29, 2021 0

Natco Pharma Limited has announced the Canadian launch of PrNAT-LENALIDOMIDE Capsules, a generic version of Celgene Corporation’s cancer drug Revlimid. The launch was announced earlier ... Read More

Janssen secures DARZALEX FASPRO FDA approval for AL amyloidosis

pharmanewsdaily- January 16, 2021 0

DARZALEX FASPRO FDA approval for AL amyloidosis : Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, has secured approval from the US Food and Drug ... Read More

Takeda’s NINLARO fails to meet PFS primary endpoint in TOURMALINE-MM2 trial

pharmanewsdaily- September 11, 2020 0

Takeda Pharmaceutical said that the Phase 3 TOURMALINE-MM2 trial in newly diagnosed multiple myeloma patients for NINLARO (ixazomib) in addition to lenalidomide and dexamethasone failed ... Read More

Janssen, Amgen secure FDA approval for DKd regiment in multiple myeloma

pharmanewsdaily- August 23, 2020 0

DKd regiment FDA approval for multiple myeloma : Janssen Pharmaceutical Companies of Johnson & Johnson and Amgen have been granted an expanded approval from the ... Read More

Dexamethasone improves survival of COVID-19 patients in RECOVERY trial

pharmanewsdaily- June 16, 2020 0

The University of Oxford said that steroid dexamethasone has succeeded in reducing death in the ongoing RECOVERY trial in hospitalized patients with severe respiratory complications ... Read More

RECOVERY coronavirus trial : First patients enrolled in COVID-19 clinical trial by University of Oxford

pallavi123- March 26, 2020 0

RECOVERY coronavirus trial : University of Oxford researchers in the UK have initiated a coronavirus clinical trial called the Randomised Evaluation of COVid-19 thERapY (RECOVERY) ... Read More

CANDOR clinical trial results : Amgen’s Kyprolis extends PFS in multiple myeloma patients

pharmanewsdaily- September 13, 2019 0

CANDOR clinical trial results : Amgen said that a phase 3 study assessing Kyprolis (carfilzomib) in combination with dexamethasone and Johnson & Johnson's Darzalex (daratumumab) ... Read More

FDA approves once-weekly dosing for Amgen’s Kyprolis in multiple myeloma treatment

pharmanewsdaily- October 2, 2018 0

The United States Food and Drug Administration (FDA) has granted approval for a new once-weekly dosing regimen of Amgen's Kyprolis (carfilzomib) in combination with dexamethasone ... Read More